Transcriptomic profiling of Schlemm's canal cells reveals a lymphatic-biased identity and three major cell states.
Schlemm's canal
cell biology
glaucoma anterior segment
mouse
single cell transcriptomics
trabecular meshwork
Journal
eLife
ISSN: 2050-084X
Titre abrégé: Elife
Pays: England
ID NLM: 101579614
Informations de publication
Date de publication:
18 Oct 2024
18 Oct 2024
Historique:
medline:
18
10
2024
pubmed:
18
10
2024
entrez:
18
10
2024
Statut:
epublish
Résumé
Schlemm's canal (SC) is central in intraocular pressure regulation but requires much characterization. It has distinct inner and outer walls, each composed of Schlemm's canal endothelial cells (SECs) with different morphologies and functions. Recent transcriptomic studies of the anterior segment added important knowledge, but were limited in power by SEC numbers or did not focus on SC. To gain a more comprehensive understanding of SC biology, we performed bulk RNA sequencing on C57BL/6 J SC, blood vessel, and lymphatic endothelial cells from limbal tissue (~4,500 SECs). We also analyzed mouse limbal tissues by single-cell and single-nucleus RNA sequencing (C57BL/6 J and 129/Sj strains), successfully sequencing 903 individual SECs. Together, these datasets confirm that SC has molecular characteristics of both blood and lymphatic endothelia with a lymphatic phenotype predominating. SECs are enriched in pathways that regulate cell-cell junction formation pointing to the importance of junctions in determining SC fluid permeability. Importantly, and for the first time, our analyses characterize three molecular classes of SECs, molecularly distinguishing inner wall from outer wall SECs and discovering two inner wall cell states that likely result from local environmental differences. Further, and based on ligand and receptor expression patterns, we document key interactions between SECs and cells of the adjacent trabecular meshwork (TM) drainage tissue. Also, we present cell type expression for a collection of human glaucoma genes. These data provide a new molecular foundation that will enable the functional dissection of key homeostatic processes mediated by SECs as well as the development of new glaucoma therapeutics.
Identifiants
pubmed: 39422453
doi: 10.7554/eLife.96459
pii: 96459
doi:
pii:
Banques de données
GEO
['GSE272434', 'GSE271132', 'GSE168200']
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : BrightFocus Foundation
ID : CG2020004
Organisme : BrightFocus Foundation
ID : G2021007S
Organisme : NEI NIH HHS
ID : R01EY028175
Pays : United States
Organisme : NEI NIH HHS
ID : R01EY032507
Pays : United States
Organisme : NEI NIH HHS
ID : R01EY032062
Pays : United States
Organisme : NEI NIH HHS
ID : R01EY029548
Pays : United States
Organisme : NEI NIH HHS
ID : R01EY022359
Pays : United States
Organisme : New York Fund for Innovation in Research and Scientific Talent
ID : EMPIRE CU19-2660
Informations de copyright
© 2024, Balasubramanian, Kizhatil et al.
Déclaration de conflit d'intérêts
RB, KK, TL, NT, AB, GC, VB, RK, SZ, JP, MS, CM, WS, JQ, SJ No competing interests declared